Abstract:Two-dimensional cell lines display a wide range of usability and are readily available in a pandemic for identifying potential pathways of infection and tissue tropism of human pathogens. SARS-CoV-2 cultured in Vero-E6 cells (monkey kidney cells) showed high sequence homology and morphology similarity compared to viruses inoculated in human airway epithelial cells [3,4]. In addition, Vero-E6 cells enable higher level of SARS-CoV-2 amplification and infectivity compared to several human cell lines including A549, Calu-3, HUH7.9, HEK-293, and U251, suggesting its usefulness in generating viral stocks for translational research [5,6]. HEK-293 cells (human embryonic kidney cells) enabled the identification of S1 and S2 subunits of the SARS-CoV-2 transmembrane spike glycoprotein as the ligands that bind host receptors [7]. Using Vero-E6 cells, these subunits were also shown to be involved in viral fusion to host cell membrane to establish infection [8]. Consequently, these cell lines have been used to evaluate drugs and vaccines response [9]. In vitro cell models also enabled the identification of host factors that are involved in SARS-CoV-2 infection. Using parental BHK-21 cells (hamster-derived), the importance of angiotensin-converting enzyme 2 (ACE2) receptor in mediating infection has been discovered [7,10]. Using human HeLa cells, several proteases including transmembrane protease serine 2 and lysosomal protease cathepsin were identified as essential determinants of viral infectivity [7,10]. In addition, genome-wide CRISPR screens in various cell lines have identified functional pathways that are involved in SARS-CoV-2 infection. Screening in Vero-E6 cells led to the discovery of several proviral genes such as HMGB1 (which plays a role in regulating ACE2 expression, hence may affect viral entry into host cells) [11] and CDK4 (which is involved in cell cycle regulation that is crucial for viral replication) [12]. Using the same cell line and technique, the SWI/SNF chromatin remodeling complex has also been identified as proviral, while the Histone H3.3 complex was proposed to have an antiviral role in SARS-CoV-2 infection [11]. While the use of 2D cellular models in research has significantly advanced our understanding on SARS-CoV-2 pathogenesis, there are several noteworthy limitations. These cell lines do not mimic the complexity of the tissue microenvironment and the in vivo conditions in the human primary airway because they are often monocultures of immortalized cells, and some are of animal origins [13,14]. For example, they may not reproduce the antiviral responses in the lungs during an infection. In addition, long-term passaging of SARS-CoV-2 in permissive cell lines may induce mutations that alter the viruses' original pathogenicity and transmissibility, thus overtime may no longer be usable for research (Fig 1A) [6,15]. Ultimately, reducing capacities to translate novel basic science discoveries to clinical trials, and some of these limitations can be addressed using 3D cultures, which are discussed in later section.

Harnessing three-dimensional (3D) cell culture models for pulmonary infections: State of the art and future directions

Short-term Ex Vivo Tissue Culture Models Help Study Human Lung Infectionsa Review

The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung‐on‐chip

3D tissue-engineered lung models to study immune responses following viral infections of the small airways

Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19

3D cell culture models in research: applications to lung cancer pharmacology

Lung-on-a-Chip Systems and Other 3D Cultures

Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects

Integration of bioprinting advances and biomechanical strategies for in vitro lung modelling

Growing Role of 3D In Vitro Cell Cultures in the Study of Cellular and Molecular Mechanisms: Short Focus on Breast Cancer, Endometriosis, Liver and Infectious Diseases

Advanced lung organoids for respiratory system and pulmonary disease modeling

Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2

Recreating chronic respiratory infections in vitro using physiologically relevant models

Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease

Advanced 3D In Vitro Lung Fibrosis Models: Contemporary Status, Clinical Uptake, and Prospective Outlooks

Recent advances in human respiratory epithelium models for drug discovery

3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery

Recent advances in lung-on-a-chip technology for modeling respiratory disease

Lung viral infection modelling in a bioengineered whole-organ

Engineered cell and tissue models of pulmonary fibrosis.